| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 51 Number 3
Volume 51S Number 1
Volume 51 Number 2
Volume 51 Number 1
Volume 50S Number 1
Volume 50 Number 6
Earlier issues
Volume 49 Number 3


Research articles

ScienceAsia 51 (2023): 1-8 |doi: 10.2306/scienceasia1513-1874.2023.059


Optimization of in vitro cell culture conditions suitable for the cholangiocarcinoma stem cell study


Krittiyabhorn Kongtanawanicha, Pornlada Likasitwatanakulb,c, Methichit Wattanapanitchd, Siwanon Jirawatnotaia,e,f,g,*

 
ABSTRACT:     Currently, cancer stem cells (CSCs) are extensively studied due to their roles in tumorigenesis, metastasis, and drug resistance. However, the low quantity, and its transient nature present a challenge for their study. Therefore, a culture system supporting high CSC quantity and flexible for high-throughput drug testing is needed. In this study, we used cholangiocarcinoma (CCA) cell lines with a CSC-specific live-cell biosensor system, which expresses green f luorescence protein (GFP) in CSCs, to study factors/conditions affecting CCA stem-like cell quantity in culture. We investigated culture media, seeding density, and compared 2-dimension (2-D) vs 3-dimensional (3-D) culture methods. The effects of anti-CCA drug dosages on CSC numbers were also studied. By comparing three media recipes, a defined serum-free CCA medium was selected for its high CSC yields. We found seeding density and time significantly influence CCACSCpercentagesinboth2-Dand3-Dsettings. Notably, 3-Dculture markedly increased CSCpercentages compared to 2-D, supporting its application in CSC studies. In 3-D culture, a higher CSC index correlated with higher anti-CCA drug doses, suggesting loss of differentiation as a prominent characteristic under standard therapy. Thus, we report culture conditions influencing CCA CSC quantity, useful for CSC study and anti-CSC drug discovery in CCA.

Download PDF

Downloads Views


a Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand
b Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University 10700 Thailand
c Department of Medicine, University of Minnesota, Minnesota 55414 USA
d Siriraj Center for Regenerative Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand
e Siriraj Center of Research Excellence for Precision Medicine and Systems Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700 Thailand
f Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 860-8555 Japan
g Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000 Thailand

* Corresponding author, E-mail: siwanon.jir@mahidol.ac.th

Received 28 Oct 2024, Accepted 0 0000